🕒 Monday 5 October 2026 Mon, 5 Oct 2026

Moab Minerals has resumed trading after lodging an annual report that shows a smaller loss but a stark liquidity warning. The uranium explorer says it needs fresh capital, creditor support and lower costs to continue operating normally.

Neurotech International has moved NTI164 into a registration-enabling Phase III autism trial, but its annual report carries a material going-concern warning. The company says post-year-end debt and equity funding should support the program through topline data, subject to execution and completion.

Vault Minerals shareholders will vote on the proposed Genesis Minerals takeover after the Supreme Court of Western Australia approved the scheme meeting. The transaction is targeted for implementation on 26 November, but still requires shareholder approval, a second court hearing and other conditions to be satisfied.

Clime Capital delivered a sharply stronger FY26 result, with after-tax profit rising to $10.3 million and dividends maintained. But KPMG qualified its audit after failing to obtain sufficient evidence for $36.2 million of unlisted unit trust valuations and related income and fees.

ReNerve’s October AGM presentation points to sharply higher sales, a growing US distribution network and a broader nerve repair pipeline. The company is also progressing a 240-patient NervAlign clinical study while relying on a $5 million RiverFort funding facility to support expansion.

333D Limited (ASX:T3D) has told the ASX it is unaware of any undisclosed information that could explain a sharp rise in its share price and trading volume. The company offered no alternative explanation for the move, which took its shares from $0.035 to an intraday high of $0.064.

Surefire Resources is seeking up to A$2.61 million through a share placement, alongside an option entitlement offer for existing eligible shareholders. The raise could materially expand the company’s securities on issue, with the second tranche and related options requiring shareholder approval.

Unity Metals has opened a non-renounceable share purchase plan targeting $1 million to fund gold and copper-gold exploration in Cambodia and Thailand. Eligible shareholders can buy shares at a 15.2% discount, with attaching options subject to a later shareholder vote.

GBM Resources has extended high-grade gold mineralisation beyond the current resource boundaries at both the 309 and Lone Sister deposits in Queensland. A further 3,550 metres of assays remain pending ahead of a planned Twin Hills resource update.

Magnetite Mines has opened a partially underwritten share purchase plan targeting approximately $1 million from eligible Australian and New Zealand shareholders. Investors who receive shares will also be entitled to one free listed option per share, subject to shareholder approval.

OD6 Metals has secured A$6.92 million from institutional and sophisticated investors to advance drilling, bulk sampling and resource definition at its Quinn Fluorspar Project in Nevada. The funding also sets up a proposed rebrand to Adaven, but brings dilution and a substantial package of shareholder approvals.

Optiscan Imaging has lodged a US FDA 510(k) application for InVue, its precision surgery device designed to provide cellular-level imaging during operations. The submission moves the technology into formal regulatory review, but clearance and commercialisation remain uncertain.

Voltaic Strategic Resources has agreed to acquire five granted Western Australian exploration licences across three gold projects for A$330,000 upfront, with up to A$2 million tied to future Rocky Ridge resource milestones. The deal broadens the explorer’s gold pipeline, but the assets remain at the target-generation stage rather than being defined resources.

Austral Resources’ proposed acquisition of Hammer Metals has cleared its first Federal Court hurdle, with ASIC registration of the Scheme Booklet and a shareholder vote now set for 9 November. The transaction still needs shareholder approval, a second Court hearing and other conditions before implementation.

PhosCo has extended mineralisation at its DOH prospect and made a new phosphate discovery at Sekarna North in Tunisia. The results are encouraging, but assays remain pending and the reported widths are reconnaissance-stage intersections rather than resource estimates.

Aspen Group delivered a stronger-than-expected first quarter, with net rental income up 16% and realised development profit nearly doubling to $7.9 million. The company maintained its FY27 targets, while warning that weaker economic conditions could disrupt development settlements.

PDI Gold has paired a strong September quarter with high-grade drilling beneath its Kiniéro pits, strengthening the case for further resource growth at Guinea’s producing gold operation. The results remain exploration-stage, but the company is preparing a 140,000-metre campaign for 2027.

Osmond Resources has secured the maximum €250,000 provisional grant in the first round of Spain’s national mineral exploration program, while preparing to start a 13-hole campaign at its Orión project. The company has also issued 85 million shares to retain its 80% interest in the project-owning vehicle.

Ingenia Communities has granted Warburg Pincus non-exclusive access to initial due diligence on its $5.25-per-security takeover proposal, bringing the rival approach into a more serious evaluation phase. The board has not endorsed the proposal and continues to progress its acquisition of Peet.

Radiopharm says the FDA has provided a clear framework for the pivotal development of RAD101, its investigational brain metastases imaging agent. The company is preparing for Phase 3 while awaiting formal meeting minutes that could still refine the trial design and regulatory requirements.

Aurora Labs has appointed Andrew Garth as chief executive, moving former CEO Rebekah Letheby into a newly focused chief operating role. The reshuffle is intended to separate commercial strategy from technical execution as the company pursues scaled manufacturing and defence opportunities.

FlexiRoam has onboarded one of Australia’s four major banks to offer complimentary global data roaming on premium rewards Mastercard cards. The live program is expected to generate about USD 140,000 a year under management’s current planning case, although there is no minimum revenue commitment.

Zenith Minerals has rejected an unsolicited $5 million capital-raising proposal from Aurenne, saying it is incomplete, difficult to implement and offers shareholders no direct consideration. The board has kept its recommendation of Forrestania Resources’ takeover offer unchanged.

Famien Resources will sell its West Yilgarn exploration portfolio to Voltaic Strategic Resources for $330,000 upfront, with a further $2 million tied to future gold resource milestones. The deal gives Famien immediate cash while leaving the larger deferred payment dependent on exploration success by the buyer.